Evaluation of Oxidative Stress by Dynamic Thiol/Disulfide Homeostasis and Ischemia-Modified Albumin Levels in Children with β-Thalassemia Major
Laboratory Medicine · 2023
DOI: 10.1093/labmed/lmac098 ↗Kurz gefasst
Fachartikel in der Zeitschrift Laboratory Medicine, 2023. Verfasst von Elif Güler Kazancı und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Hematology, University of Health Sciences, Bursa City Training and Research Hospital, Bursa, Turkey. Hauptthemen laut MEDLINE: Antioxidants, beta-Thalassemia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Objective β-thalassemia major (β-TM) is a hemoglobinopathy characterized by reduced or absent β-globin production. A balance remains between the production of free radicals and suppression of increased levels of reactive oxygen species by the antioxidant system. This study aimed to examine thiol/disulfide homeostasis (TDH) and serum ischemia-modified albumin (IMA) levels to evaluate the oxidant/antioxidant balance in healthy children and persons with β-TM receiving and not receiving chelation therapy.
Methods
This prospective study was carried out from January to June 2021 among 46 individuals with β-TM and 35 healthy controls. A spectrophotometric method was used to analyze TDH and IMA concentrations.
Results
We found that, compared to controls, native thiol (NT) (P = .048) and total thiol (TT) (P = .027) values were lower in the patient group, whereas disulfide (P < .001), disulfide/native thiol (D/NT) (P = .004), disulfide/total thiol (D/TT) (P = .005), native thiol/total thiol (NT/TT) (P = .004) and IMA (P = .045) values were higher. NT and TT levels were significantly lower in the chelation− group compared to the chelation+ and control groups (P = .002, P = .001). D/NT, D/TT, and NT/TT levels were higher in the chelation+ group than the control group (P = .007), and IMA levels were significantly higher in the chelation+ and chelation− groups compared to the control group (P = .002). The receiver operating characteristic analysis demonstrated that IMA levels were significantly higher in the children with β-TM not taking regular chelation therapy.
Conclusion
Thiol/disulfide homeostasis was observed to be weakened in children with β-TM in our study. Our findings show that when children with β-TM do not receive regular chelation therapy, their oxidant imbalance worsens.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatric Hematology, University of Health Sciences, Bursa City Training and Research Hospital, Bursa, Turkey.
- Department of Pediatrics, University of Health Sciences, Bursa City Training and Research Hospital, Bursa, Turkey.
- Department of Biochemistry, University of Health Sciences, Ankara City Training and Research Hospital, Ankara, Turkey.
- Department of Biochemistry, Faculty of Medicine, Yıldırım Beyazıt University, Ankara, Turkey.
ORCID-Profile: Muhammet Furkan Korkmaz, Funda Eren
Zitieren
APA
Güler Kazancı, E., Korkmaz, M. F., Eren, F., & Erel, Ö. (2023). Evaluation of Oxidative Stress by Dynamic Thiol/Disulfide Homeostasis and Ischemia-Modified Albumin Levels in Children with β-Thalassemia Major. Laboratory Medicine. https://doi.org/10.1093/labmed/lmac098
Vancouver
Güler Kazancı E, Korkmaz MF, Eren F, Erel Ö. Evaluation of Oxidative Stress by Dynamic Thiol/Disulfide Homeostasis and Ischemia-Modified Albumin Levels in Children with β-Thalassemia Major. Laboratory Medicine. 2023. doi:10.1093/labmed/lmac098
BibTeX
@article{GlerKazanc2023,
author = {Güler Kazancı, Elif and Korkmaz, Muhammet Furkan and Eren, Funda and Erel, Özcan},
title = {Evaluation of Oxidative Stress by Dynamic Thiol/Disulfide Homeostasis and Ischemia-Modified Albumin Levels in Children with β-Thalassemia Major},
journal = {Laboratory Medicine},
year = {2023},
doi = {10.1093/labmed/lmac098}
}
EUVIMED